BOT botanix pharmaceuticals ltd

Ann: Botanix Secures Commercial-Scale Synthetic Cannabidiol-BOT.AX, page-3

  1. 7,060 Posts.
    lightbulb Created with Sketch. 218
    Hmm, so it seems they've chosen a synthetic product over natural because ...

    "the Company will not be required to comply with the extensive testing and controls in the US Food and Drug Administration’s (FDA) “Guidance for Botanical Drug Products” that apply to natural cannabidiol extract based products."

    ... along with it being more consistent and pure. It's probably cheaper to manufacture also, which is good for the balance sheet.

    However, my concern is that the whole point of using cannabis for medicinal purposes is to take advantage of it's natural qualities. Manufacturing a synthetic version of the real thing may be cheaper and easier to get FDA approved, but will it actually work???
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $323.5M
Open High Low Value Volume
17.0¢ 18.0¢ 16.0¢ $3.657M 21.63M

Buyers (Bids)

No. Vol. Price($)
2 180978 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 529694 12
View Market Depth
Last trade - 16.18pm 28/07/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.